Guggenheim Capital’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $623K | Sell |
123,060
-23,479
| -16% | -$119K | ﹤0.01% | 1068 |
|
|
2025
Q1 | $775K | Buy |
146,539
+3,482
| +2% | +$18.4K | 0.01% | 988 |
|
|
2024
Q4 | $967K | Sell |
143,057
-12,173
| -8% | -$82.3K | 0.01% | 933 |
|
|
2024
Q3 | $1.02M | Buy |
155,230
+31,724
| +26% | +$209K | 0.01% | 1089 |
|
|
2024
Q2 | $926K | Buy |
123,506
+81,325
| +193% | +$610K | 0.01% | 1159 |
|
|
2024
Q1 | $421K | Sell |
42,181
-1,592
| -4% | -$15.9K | ﹤0.01% | 1538 |
|
|
2023
Q4 | $432K | Sell |
43,773
-158
| -0.4% | -$1.56K | ﹤0.01% | 1511 |
|
|
2023
Q3 | $336K | Buy |
43,931
+27,119
| +161% | +$207K | ﹤0.01% | 1586 |
|
|
2023
Q2 | $126K | Buy |
+16,812
| New | +$126K | ﹤0.01% | 1817 |
|